arrow
C

Christian Heiß

University of Surrey
H指数:61
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lipid lowering therapy in venous thromboembolism. A Clinical Consensus Statement of the ESC Working Group on Aorta and Peripheral Vascular Diseases, the ESC Working Group on Cardiovascular Pharmacotherapy, the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, and the European Society of Vascular Medicine (ESVM)

静脉血栓栓塞症的降脂治疗。欧洲心脏病学会主动脉和外周血管疾病工作组、欧洲心脏病学会心血管药物治疗工作组、欧洲心脏病学会肺循环与右心室功能工作组以及欧洲血管医学学会(ESVM)的临床共识声明

2026-09-090
OAAI
Machine-learning for photoplethysmography analysis: Benchmarking feature, image, and signal-based approaches

机器学习方法在光电容积脉搏波描记法分析中的应用:基于特征、图像和信号方法的基准比较

2026-02-250
OAAI
The year in vascular medicine: Highlights in Vasa - European Journal of Vascular Medicine 2025

2025年血管医学年度回顾:《Vasa - 欧洲血管医学杂志》亮点

2026-01-010
PRE
Optimal treatment of preclinical cardiovascular disease: a narrative review with a focus on carotid artery stenosis

心血管疾病前临床期的最佳治疗:一篇以颈动脉狭窄为重点的叙事性综述

2025-11-270
PRE
Cocoa flavanols alleviate early diastolic dysfunction by decreasing left atrial volume in a randomized double blinded trial in healthy older individuals

可可黄烷醇通过减少左心房容积,在随机双盲试验中缓解健康老年人早期舒张功能障碍。

2025-10-270
OAAI
The Future of Vascular Medicine in Europe - Insights from the ESVM Survey on Training Experiences and Career Perspectives An analysis of opportunities and challenges for advancing a vital specialty in the European healthcare landscape

欧洲血管医学的未来——来自ESVM关于培训经历和职业前景的调查见解 对在欧盟医疗保健格局中推进这一重要专业领域的机遇与挑战的分析

2025-09-010
OA
Role of glucuronoxylomannan and steryl glucosides in protecting against cryptococcosis

葡糖醛酸木糖甘露聚糖和甾基葡糖苷在抗隐球菌病中的作用

MBIO
IF4.7
2025-06-110
OA
Applying a polysaccharide lyase from Stenotrophomonas maltophilia to disrupt alginate exopolysaccharide produced by Pseudomonas aeruginosa clinical isolates

应用嗜麦芽窄食单胞菌的多糖裂解酶破坏铜绿假单胞菌临床分离株产生的藻酸盐外多糖

2025-01-310
OAAI
Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma (vol 17, 128, 2024)

硼替佐米释放的硅酸-胶原蛋白干凝胶用于多发性骨髓瘤的溶骨性骨病和微小残留病灶的局部治疗(卷17,128,2024)

2025-01-240
OA
Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma

释放硼替佐米的二氧化硅-胶原干燥凝胶用于局部治疗多发性骨髓瘤的溶骨性骨和最小残留疾病

2024-12-180
OAAI